These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10363588)

  • 1. Efficient production of adeno-associated virus vectors using split-type helper plasmids.
    Ogasawara Y; Urabe M; Kogure K; Kume A; Colosi P; Kurtzman GJ; Ozawa K
    Jpn J Cancer Res; 1999 Apr; 90(4):476-83. PubMed ID: 10363588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector production.
    Johari YB; Pohle TH; Whitehead J; Scarrott JM; Liu P; Mayer A; James DC
    Biotechnol J; 2024 Jun; 19(6):e2300685. PubMed ID: 38900035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of heterologous promoters for adeno-associated virus (AAV) protein expression in AAV vector production.
    Ogasawara Y; Urabe M; Ozawa K
    Microbiol Immunol; 1998; 42(3):177-85. PubMed ID: 9570283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels.
    Kyöstiö SR; Owens RA; Weitzman MD; Antoni BA; Chejanovsky N; Carter BJ
    J Virol; 1994 May; 68(5):2947-57. PubMed ID: 8151765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
    Fan PD; Dong JY
    Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.
    Weger S; Wistuba A; Grimm D; Kleinschmidt JA
    J Virol; 1997 Nov; 71(11):8437-47. PubMed ID: 9343200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
    Cao L; Liu Y; During MJ; Xiao W
    J Virol; 2000 Dec; 74(24):11456-63. PubMed ID: 11090141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant.
    Hölscher C; Kleinschmidt JA; Bürkle A
    J Virol; 1995 Nov; 69(11):6880-5. PubMed ID: 7474103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
    Grimm D; Kay MA; Kleinschmidt JA
    Mol Ther; 2003 Jun; 7(6):839-50. PubMed ID: 12788658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
    Collaco RF; Cao X; Trempe JP
    Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
    Shi S; Mercer SA; Dilley R; Trippel SB
    Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
    Xiao X; Li J; Samulski RJ
    J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for highly regulated rep gene expression in adeno-associated virus vector production.
    Li J; Samulski RJ; Xiao X
    J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
    Whiteway A; Deru W; Prentice HG; Anderson R
    J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.
    Smith RH; Afione SA; Kotin RM
    Biotechniques; 2002 Jul; 33(1):204-6, 208, 210-1. PubMed ID: 12139247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines.
    Qiao C; Wang B; Zhu X; Li J; Xiao X
    J Virol; 2002 Dec; 76(24):13015-27. PubMed ID: 12438627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells.
    Antoni BA; Rabson AB; Miller IL; Trempe JP; Chejanovsky N; Carter BJ
    J Virol; 1991 Jan; 65(1):396-404. PubMed ID: 1845899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.